At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Influence of Mucosa Tissue Thickness on Marginal Bone Loss of Implants With Smooth Collars: A Prospective Controlled Trial
In Brief
A clinical study evaluating Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) for Gingival Tissue. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The primary objective of this study is to compare the amount of implant marginal bone loss radiographically and probing depth in between thin and thick mucosa group that will receive a machined collar implant. Null hypothesis is mucosa thickness does not affect implant marginal bone loss on implant with smooth collar.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGingival Tissue
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 2016
Enrollment StartNov 2016
Primary CompletionDec 2019
TodayJul 2026
First PostedOct 5, 2016
Enrollment StartNov 21, 2016
Primary CompletionDec 16, 2019
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 9.7 years ago
Interventions
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT)device
Placement of implant in a subject with \<2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.